Terveystalo Oy(GB:0RV1)
€6.12-0.05 (-0.89%)
GB:0RV1
Terveystalo Oy financials statements
€6.12
At close:-0.05 (-0.89%)
Terveystalo Oy (0RV1) Ratios
0 Followers
Terveystalo Oy Ratios
GB:0RV1's free cash flow for Q3 2026 was €19.20M. For the 2026 fiscal year, GB:0RV1's free cash flow was decreased by €-3.90M and operating cash flow was €23.10M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.64 | 0.65 | 0.64 | 0.62 | 0.44 |
| Quick Ratio | 0.61 | 0.63 | 0.62 | 0.60 | 0.42 |
| Cash Ratio | 0.23 | 0.20 | 0.13 | 0.13 | 0.10 |
| Solvency Ratio | 0.22 | 0.20 | 0.07 | 0.14 | 0.20 |
| Operating Cash Flow Ratio | 0.57 | 0.70 | 0.53 | 0.46 | 0.50 |
| Short-Term Operating Cash Flow Coverage | 3.84 | 7.53 | 7.98 | 3.52 | 1.69 |
| Net Current Asset Value | € -649.30M | € -642.00M | € -711.50M | € -697.70M | € -666.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.40 | 0.41 | 0.45 | 0.41 | 0.38 |
| Debt-to-Equity Ratio | 0.99 | 1.04 | 1.23 | 1.03 | 0.92 |
| Debt-to-Capital Ratio | 0.50 | 0.51 | 0.55 | 0.51 | 0.48 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 0.39 | 0.43 | 0.39 | 0.29 |
| Financial Leverage Ratio | 2.47 | 2.55 | 2.75 | 2.50 | 2.38 |
| Debt Service Coverage Ratio | 2.97 | 3.52 | 2.04 | 2.74 | 1.44 |
| Interest Coverage Ratio | 6.25 | 4.30 | -0.63 | 6.42 | 11.12 |
| Debt to Market Cap | 0.31 | 0.28 | 0.42 | 0.53 | 0.24 |
| Interest Debt Per Share | 4.76 | 4.72 | 5.21 | 4.88 | 4.46 |
| Net Debt to EBITDA | 2.17 | 2.32 | 6.54 | 3.93 | 2.58 |
| Profitability Margins | |||||
| Gross Profit Margin | 21.09% | 58.97% | 23.57% | 58.25% | 57.66% |
| EBIT Margin | 10.76% | 8.60% | -1.20% | 3.23% | 9.61% |
| EBITDA Margin | 18.26% | 16.22% | 7.11% | 11.47% | 17.44% |
| Operating Profit Margin | 10.76% | 8.66% | -1.14% | 5.31% | 9.54% |
| Pretax Profit Margin | 9.09% | 6.69% | -3.02% | 2.45% | 8.72% |
| Net Profit Margin | 7.24% | 5.35% | -3.28% | 1.94% | 6.97% |
| Continuous Operations Profit Margin | 7.25% | 5.34% | -3.28% | 1.95% | 7.00% |
| Net Income Per EBT | 79.69% | 80.02% | 108.48% | 78.96% | 79.94% |
| EBT Per EBIT | 84.45% | 77.17% | 264.63% | 46.26% | 91.46% |
| Return on Assets (ROA) | 6.43% | 5.13% | -2.97% | 1.65% | 5.56% |
| Return on Equity (ROE) | 15.85% | 13.08% | -8.19% | 4.12% | 13.22% |
| Return on Capital Employed (ROCE) | 12.34% | 10.76% | -1.31% | 5.70% | 10.42% |
| Return on Invested Capital (ROIC) | 9.08% | 8.03% | -1.24% | 4.18% | 7.18% |
| Return on Tangible Assets | 17.74% | 14.72% | -8.51% | 5.36% | 18.95% |
| Earnings Yield | 7.48% | 5.38% | -4.31% | 3.09% | 5.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.24 | 11.22 | 10.08 | 10.33 | 9.59 |
| Payables Turnover | 4.75 | 2.39 | 19.86 | 10.73 | 8.56 |
| Inventory Turnover | 132.79 | 76.36 | 138.48 | 79.65 | 76.38 |
| Fixed Asset Turnover | 4.48 | 4.95 | 4.34 | 4.92 | 4.72 |
| Asset Turnover | 0.89 | 0.96 | 0.91 | 0.85 | 0.80 |
| Working Capital Turnover Ratio | -11.12 | -12.23 | -11.44 | -7.49 | -6.77 |
| Cash Conversion Cycle | -38.42 | -115.59 | 20.46 | 5.90 | 0.20 |
| Days of Sales Outstanding | 35.65 | 32.52 | 36.20 | 35.34 | 38.06 |
| Days of Inventory Outstanding | 2.75 | 4.78 | 2.64 | 4.58 | 4.78 |
| Days of Payables Outstanding | 76.82 | 152.89 | 18.38 | 34.02 | 42.64 |
| Operating Cycle | 38.40 | 37.30 | 38.84 | 39.92 | 42.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.48 | 1.77 | 1.25 | 1.11 | 1.53 |
| Free Cash Flow Per Share | 1.23 | 1.45 | 0.92 | 0.65 | 1.20 |
| Dividend Paid and CapEx Coverage Ratio | 2.04 | 2.88 | 2.07 | 1.49 | 2.56 |
| Capital Expenditure Coverage Ratio | 6.08 | 5.65 | 3.85 | 2.38 | 4.53 |
| Operating Cash Flow Coverage Ratio | 0.32 | 0.39 | 0.25 | 0.23 | 0.35 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.17 | 0.12 | 0.11 | 0.17 |
| Free Cash Flow Yield | 12.63% | 13.82% | 11.94% | 10.33% | 10.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.40 | 18.46 | -23.21 | 32.40 | 18.71 |
| Price-to-Sales (P/S) Ratio | 0.97 | 0.99 | 0.76 | 0.63 | 1.30 |
| Price-to-Book (P/B) Ratio | 2.12 | 2.43 | 1.90 | 1.34 | 2.47 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.92 | 7.23 | 8.37 | 9.68 | 9.90 |
| Price-to-Operating Cash Flow Ratio | 6.62 | 5.95 | 6.20 | 5.61 | 7.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.48 | -0.07 | 0.08 | -0.46 | 0.25 |
| Enterprise Value Multiple | 7.47 | 8.45 | 17.24 | 9.40 | 10.05 |
| Enterprise Value | 1.74B | 1.84B | 1.58B | 1.36B | 2.03B |
| EV to EBITDA | 7.47 | 8.45 | 17.24 | 9.40 | 10.05 |
| EV to Sales | 1.36 | 1.37 | 1.23 | 1.08 | 1.75 |
| EV to Free Cash Flow | 11.15 | 9.98 | 13.48 | 16.62 | 13.31 |
| EV to Operating Cash Flow | 9.32 | 8.21 | 9.99 | 9.63 | 10.37 |
| Tangible Book Value Per Share | -2.65 | -2.87 | -3.22 | -3.42 | -3.26 |
| Shareholders’ Equity Per Share | 4.61 | 4.33 | 4.07 | 4.68 | 4.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.20 | -0.08 | 0.21 | 0.20 |
| Revenue Per Share | 10.10 | 10.58 | 10.16 | 9.95 | 9.08 |
| Net Income Per Share | 0.73 | 0.57 | -0.33 | 0.19 | 0.63 |
| Tax Burden | 0.80 | 0.80 | 1.08 | 0.79 | 0.80 |
| Interest Burden | 0.84 | 0.78 | 2.53 | 0.76 | 0.91 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| SG&A to Revenue | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.02 | 2.50 | -3.74 | 4.56 | 1.94 |
Currency in EUR

